Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 Jun 2017
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors AstraZeneca
- 13 Mar 2017 Planned End Date changed from 1 Jul 2019 to 31 Jul 2019.
- 13 Mar 2017 Planned primary completion date changed from 1 Jul 2019 to 31 Jul 2019.
- 28 Apr 2016 Status changed from recruiting to active, no longer recruiting.